NIPT Explained: What the Test Screens For, Accuracy, and Timing

NIPT is one of the first big tests many people are offered in pregnancy, and it can feel confusing. The science sounds complicated, the brochure is dense, and the results wording is genuinely easy to misread. A “high risk” result can sound like a diagnosis when it is not, and a “low risk” result can sound like a promise when it is not quite that either. Here is a clear, calm guide to what NIPT actually does, what it can and cannot tell you, and how to make sense of the result you get.

What is NIPT?

NIPT stands for non-invasive prenatal testing. You may also hear it called cell-free DNA screening. It is a single blood draw from your arm, with nothing invasive involved for you or your baby. During pregnancy, small fragments of DNA from the placenta circulate in your bloodstream alongside your own DNA. The lab measures these fragments and looks for patterns that suggest your baby may have an extra or missing copy of certain chromosomes.

Because the placenta is the source of that DNA, the test reads placental information as a stand-in for the baby. That is usually a good match, but it is one reason NIPT is a screen rather than a final answer. It often comes up early, around the same time as your first trimester appointments and bloodwork.

What does NIPT screen for?

The core of NIPT is screening for the most common chromosomal conditions. These are:

• Trisomy 21 (Down syndrome): an extra copy of chromosome 21. This is the condition NIPT detects most reliably.
• Trisomy 18 (Edwards syndrome): an extra copy of chromosome 18.
• Trisomy 13 (Patau syndrome): an extra copy of chromosome 13.
• Sex chromosome conditions: differences in the number of X or Y chromosomes, such as Turner syndrome or Klinefelter syndrome.
• Baby’s sex: because the test reads the sex chromosomes, it can also report whether your baby is likely a boy or a girl. That part is a bonus, and it is the same information many people use when finding out your baby’s sex early.

Some labs offer expanded panels that add screening for microdeletions or other rarer conditions. It is worth knowing that these expanded options tend to be less reliable than the core trisomy screening, with more false alarms, so many providers and professional groups are cautious about them. If you are offered an expanded panel, ask what it adds and how dependable it really is.

When is NIPT done?

NIPT is usually offered from about 10 weeks of pregnancy. Before that point, there is often not enough of the baby’s DNA in your blood for the test to work well, which can lead to an inconclusive result. There is no upper limit, so it can be done later in pregnancy too. Drawing it around 10 to 13 weeks lets the result come back in time to plan any follow-up, including diagnostic testing if you choose it.

How accurate is NIPT?

This is where the wording matters most. For Down syndrome, NIPT has a very high detection rate, meaning it correctly flags most pregnancies that are affected. That is genuinely strong performance for a screening test. But high detection is not the same as certainty, and one number explains why: the positive predictive value.

Positive predictive value is the chance that a “high risk” result is truly correct. It varies with your age and with the specific condition. Because these conditions are uncommon overall, a screen-positive result can still turn out to be a false alarm, especially for the rarer trisomies and in younger people where the baseline chance is lower. In plain terms, a screen-positive result does not mean your baby has the condition. It means the odds are higher than average and a confirmatory diagnostic test is the next step to know for sure.

Screening test versus diagnostic test

Feature	NIPT (screening)	CVS or amniocentesis (diagnostic)
What it tells you	Risk level: higher or lower chance	A definitive yes or no answer
How it is done	Simple blood draw from your arm	A sample of placenta (CVS) or amniotic fluid (amnio)
Risk to pregnancy	None to the pregnancy	Small risk, including a low chance of miscarriage
Timing	From about 10 weeks	CVS around 10 to 13 weeks; amnio from about 15 weeks
Result	Low risk or high risk, not a diagnosis	Confirms or rules out the condition

What do the results mean?

NIPT results come back as a risk level, not a simple yes or no. A low risk result means it is unlikely your baby has the conditions screened for. It is reassuring, and for most people it is the result they receive. It is not a guarantee, though. No screening test rules everything out, and your other routine care, including the 20-week anatomy scan, still has an important role to play.

A high risk result means the chance is higher than average and deserves a closer look. It is not a diagnosis, and it does not mean a decision has to be made on the spot. Occasionally a result comes back inconclusive or with “no call,” often because there was not enough placental DNA in the sample. That usually means a repeat draw rather than anything being wrong.

What happens after a high-risk result?

If your NIPT comes back high risk, the first step is usually a conversation, not a procedure. Your provider will typically offer genetic counseling, where someone walks you through what the result does and does not mean, what your actual numbers look like, and what your options are. There is no rush to decide anything in that moment.

From there, a diagnostic test is the way to get a definite answer. Chorionic villus sampling (CVS) samples a small piece of the placenta and can be done earlier, while amniocentesis samples a little amniotic fluid and is done from about 15 weeks. Both carry a small risk, including a low chance of miscarriage, which is exactly why they are reserved for confirming a result rather than being offered to everyone. Some people choose diagnostic testing, and some choose to continue without it. Either choice is valid, and a genetic counselor can help you think it through.

Cost and coverage

Cost is one of the least predictable parts of NIPT. Whether it is covered, and how much you pay out of pocket, depends on your insurance, your medical history, your age, and where you live. Some plans cover it fully for everyone, some only for certain situations, and some not at all. Expanded panels are more likely to add cost. Before booking, it is worth asking your provider and your insurer what is covered, and asking the lab about any patient pricing or financial assistance.

Questions to ask your provider

• Which conditions does this specific test screen for, and does it include an expanded panel?
• What is the positive predictive value for someone my age?
• Is this test covered by my insurance, and what might I pay out of pocket?
• If the result is high risk, what are my next steps and what does diagnostic testing involve?
• What happens if the result is inconclusive or comes back as no call?
• Can I speak with a genetic counselor before or after the test?

Medical disclaimer: This article is for general educational purposes only and is not medical advice. It does not replace care from a doctor, midwife, genetic counselor, or other qualified professional. Always discuss your screening and diagnostic options with your provider or a genetic counselor, who can explain what any result means for your individual pregnancy. If you think you may be experiencing a medical emergency, contact your local emergency services right away.

Sources

• American College of Obstetricians and Gynecologists. “Cell-free DNA Prenatal Screening Test.” 2024.
• Society for Maternal-Fetal Medicine. “Prenatal Screening for Fetal Aneuploidy.” 2024.
• National Health Service (UK). “Screening for Down’s, Edwards’ and Patau’s syndromes.” 2025.
• American College of Obstetricians and Gynecologists. “Prenatal Genetic Diagnostic Tests.” 2023.